HCA Healthcare (NYSE:HCA) PT Lowered to $360.00

HCA Healthcare (NYSE:HCA) had its price objective cut by TD Cowen from $371.00 to $360.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. TD Cowen’s price target would suggest a potential upside of 16.34% from the company’s current price.

HCA has been the subject of several other reports. Wells Fargo & Company upped their target price on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Sanford C. Bernstein downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating and upped their price objective for the company from $277.00 to $301.00 in a research note on Thursday, January 4th. Truist Financial upped their price objective on HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Finally, Barclays increased their target price on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research report on Monday. Four equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $316.59.

HCA Healthcare Stock Performance

Shares of HCA opened at $309.44 on Tuesday. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The stock has a 50 day moving average price of $323.07 and a two-hundred day moving average price of $296.64. The firm has a market capitalization of $81.84 billion, a P/E ratio of 15.43, a P/E/G ratio of 1.48 and a beta of 1.65. HCA Healthcare has a 52 week low of $215.96 and a 52 week high of $335.83.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same period in the previous year, the company posted $4.93 EPS. Equities analysts forecast that HCA Healthcare will post 20.82 earnings per share for the current fiscal year.

HCA Healthcare declared that its board has approved a share buyback plan on Tuesday, January 30th that permits the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 7.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

Insider Activity at HCA Healthcare

In related news, SVP Chad J. Wasserman sold 876 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now owns 1,576 shares of the company’s stock, valued at $520,474. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Chad J. Wasserman sold 344 shares of HCA Healthcare stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $321.97, for a total value of $110,757.68. Following the completion of the transaction, the senior vice president now owns 2,452 shares in the company, valued at approximately $789,470.44. The disclosure for this sale can be found here. Insiders have sold a total of 7,779 shares of company stock valued at $2,421,814 over the last 90 days. 1.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Parkside Financial Bank & Trust increased its holdings in HCA Healthcare by 8.2% during the 4th quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after purchasing an additional 35 shares during the period. FinTrust Capital Advisors LLC increased its holdings in HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after purchasing an additional 35 shares during the period. Ballentine Partners LLC boosted its position in HCA Healthcare by 1.0% during the 1st quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock valued at $1,294,000 after acquiring an additional 38 shares in the last quarter. Wedmont Private Capital boosted its position in shares of HCA Healthcare by 1.6% in the 4th quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock worth $711,000 after purchasing an additional 39 shares in the last quarter. Finally, Valley Wealth Managers Inc. boosted its position in shares of HCA Healthcare by 4.1% in the 4th quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock worth $266,000 after purchasing an additional 39 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.